Goldman SachsGSSELLSep 15, 2014Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Financial stocks tend to do well in the first 4 months of the year, but this one is a bit different. It can do well in the summer, June until about right now. Chart shows a huge run-up in the stock. The trend is favourable right now but we are reaching the end of the seasonal strength and we are liable to enter a period of seasonal weakness, which stretches through to November. If you own, he would suggest taking profits now. Seasonal strength is January through to April.